Diabetes linked to increased cause-specific mortality

June 21, 2012
Diabetes linked to increased cause-Specific mortality
Diabetes is linked with a significantly increased risk of death from many diseases, including specific cancers, in both men and women, according to a study published online June 14 in Diabetes Care.

(HealthDay) -- Diabetes is linked with a significantly increased risk of death from many diseases, including specific cancers, in both men and women, according to a study published online June 14 in Diabetes Care.

Peter T. Campbell, Ph.D., of the National Home Office in Atlanta, and colleagues conducted a involving 1,053,831 adults in the United States enrolled in the Cancer Prevention Study-II who were followed for up to 26 years. Participants completed a self-administered questionnaire at baseline, and the association of diabetes with cause-specific mortality was assessed.

The researchers found that women and men with diabetes had an increased risk of all-cause mortality, after controlling for age, , and other variables (relative risk [RR], 1.90 and 1.73, respectively). Diabetes correlated with increased risk of death from cancers of the liver (RR, 1.40), pancreas (RR, 1.31), endometrium (RR, 1.33), colon (RR, 1.18), and breast (RR, 1.16) for women. For men there was an increased risk of death from cancers of the breast (RR, 4.20), liver (2.26), oral cavity and pharynx (RR, 1.44), pancreas (RR, 1.40), bladder (RR, 1.22), and colon (RR, 1.15). There was an inverse association with prostate cancer (RR, 0.88). Diabetes correlated with increased mortality linked to the circulatory system, respiratory system, digestive system, genitourinary system, and accidental deaths/external causes.

"In conclusion, the broad range of deaths associated with diabetes in this study reflect the extensive nature of the disease," the authors write. "These findings support the need for coordinated, multidisciplinary care of men and women with diabetes, including age-appropriate and early detection."

Explore further: Study links acetaminophen to lower prostate cancer risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study links acetaminophen to lower prostate cancer risk

May 23, 2011

A new study from American Cancer Society researchers finds use of 30 tablets a month or more of acetaminophen for five or more years was associated with an estimated 38% lower risk of prostate cancer. The study appears in ...

Declines in melanoma deaths limited to the most educated

January 16, 2012

A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening ...

Cancer risk up in bilateral retinoblastoma survivors

February 23, 2012

(HealthDay) -- For survivors of bilateral retinoblastoma (Rb), family history is associated with an increased risk of second cancers (SCs), especially melanoma, according to a study published online Feb. 21 in the Journal ...

Smoking is an independent risk factor for psoriasis

March 7, 2012

(HealthDay) -- Smoking is an independent risk factor for psoriasis, with particularly strong associations for heavy smokers and those who have smoked for many years, according to research published in the March 1 issue of ...

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.